The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 353:1402-1404 September 29, 2005 Number 13
NextNext

Immunotherapy for Congenital Cytomegalovirus Infection
Patrick Duff, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Nigro, G.
-PubMed Citation
Cytomegalovirus (CMV) is an extremely important perinatal pathogen. Each year, approximately 1 percent of susceptible women seroconvert during pregnancy. Although sexual transmission of CMV can occur, most pregnant women acquire CMV infection through exposure to children in their own home or from occupational exposure to children in day care or elementary school. Exposure typically occurs as a result of contact with contaminated saliva, urine, or fomites such as toys. Approximately 40 percent of pregnant women with a primary infection transmit CMV to their fetuses. Rates of transmission are highest when maternal infection occurs in the third trimester; however, the risk . . . [Full Text of this Article]


Source Information

From the Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.